Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07417969

"Effect of Albumin Combined With Furosemide in Critically Ill Patients With Fluid Overload: Impact on Urine Output and Renal Function"

Led by Jose J Zaragoza, MD MSc · Updated on 2026-02-18

56

Participants Needed

1

Research Sites

73 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to compare the effectiveness of furosemide alone versus the combination of furosemide plus albumin in critically ill adult patients with fluid overload. The trial evaluates whether co-administration of albumin enhances diuretic response compared with standard furosemide therapy. The primary outcomes include urine output at 2 hours, changes in renal perfusion markers, and biochemical parameters. Secondary outcomes include changes in mean arterial pressure, electrolyte balance, and renal resistance index. The study seeks to determine whether adding albumin provides a clinically meaningful improvement in diuresis and renal function compared with furosemide monotherapy.

CONDITIONS

Official Title

"Effect of Albumin Combined With Furosemide in Critically Ill Patients With Fluid Overload: Impact on Urine Output and Renal Function"

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 218 years or older admitted to the ICU without mechanical ventilation
  • Starting diuretic therapy for the first time during the ICU stay due to fluid overload as determined by the treating physician
Not Eligible

You will not qualify if you...

  • Patients or family members who refuse participation
  • Patients receiving palliative care
  • Patients with kidney failure requiring renal replacement therapy
  • Patients currently in another clinical research study
  • Patients with signs of low blood volume or dehydration

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

76000

Querétaro City, Querétaro, Mexico, 26089

Actively Recruiting

Loading map...

Research Team

A

Alina Elizabeth Arechiga Casas, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here